Literature DB >> 2508660

Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.

H Fujiki1, M Suganuma, S Yoshizawa, H Kanazawa, T Sugimura, S Manam, S M Kahn, W Jiang, S Hoshina, I B Weinstein.   

Abstract

Three okadaic acid class tumor promoters, okadaic acid, dinophysistoxin-1, and calyculin A, have potent tumor-promoting activity in two-stage carcinogenesis experiments on mouse skin. DNA isolated from tumors induced by 7,12-dimethylbenz[a]anthracene (DMBA) and each of these tumor promoters revealed the same mutation at the second nucleotide of codon 61 (CAA----CTA) in the c-Ha-ras gene, determined by the polymerase chain reaction procedure and DNA sequencing. Three potent 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters, TPA, teleocidin, and aplysiatoxin, showed the same effects. These results provide strong evidence that this mutation in the c-Ha-ras gene is due to a direct effect of DMBA rather than a selective effect of specific tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508660     DOI: 10.1002/mc.2940020403

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

1.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

2.  TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.

Authors:  Hiroyuki Yamamoto; Joohyun Ryu; Eli Min; Naomi Oi; Ruihua Bai; Tatyana A Zykova; Dong Hoon Yu; Kenji Moriyama; Ann M Bode; Zigang Dong
Journal:  J Invest Dermatol       Date:  2017-01-25       Impact factor: 8.551

3.  Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR.

Authors:  R Nishiwaki-Matsushima; T Ohta; S Nishiwaki; M Suganuma; K Kohyama; T Ishikawa; W W Carmichael; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.

Authors:  Katherine L Jameson; Pawel K Mazur; Ashley M Zehnder; Jiajing Zhang; Brian Zarnegar; Julien Sage; Paul A Khavari
Journal:  Nat Med       Date:  2013-04-21       Impact factor: 53.440

5.  Frequent K-ras mutations in small bowel adenocarcinomas.

Authors:  T Sutter; N Arber; S F Moss; R I Findling; A I Neugut; I B Weinstein; P R Holt
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 6.  Tumor promoters: from chemicals to inflammatory proteins.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-12       Impact factor: 4.553

7.  The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.

Authors:  Dhrubajyoti Chakravarti; Divya Venugopal; Paula C Mailander; Jane L Meza; Sheila Higginbotham; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Mutat Res       Date:  2007-09-07       Impact factor: 2.433

8.  Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis.

Authors:  Philbert Lee; Shangwen Jiang; Yuanyuan Li; Jiping Yue; Xuewen Gou; Shao-Yu Chen; Yingming Zhao; Markus Schober; Minjia Tan; Xiaoyang Wu
Journal:  EMBO J       Date:  2017-05-15       Impact factor: 11.598

9.  Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Authors:  H Fujiki; M Suganuma; S Yoshizawa; S Nishiwaki; B Winyar; T Sugimura
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

10.  Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.

Authors:  Mary B Kelley; Taylor J Geddes; Maria Ochiai; Noah M Lampl; W Wade Kothmann; Sara R Fierstein; Victoria Kent; Kathleen DeCicco-Skinner
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.